Advertisement
U.S. markets closed

Sientra, Inc. (SIEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.17400.0000 (0.00%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.1740
Open0.1850
Bid0.0000 x 1800
Ask0.0000 x 800
Day's Range0.1740 - 0.1740
52 Week Range0.1566 - 4.9373
Volume3,327,525
Avg. Volume2,441,321
Market Cap2.081M
Beta (5Y Monthly)2.03
PE Ratio (TTM)N/A
EPS (TTM)-5.2600
Earnings DateMar 28, 2024 - Apr 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SIEN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sientra, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • GlobeNewswire

    Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

    Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale processIRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing and commercializing safe and innovative solutions for the best aesthetic outcomes, announced that it filed for Chapter 11 protection in the United States Bankruptcy Court for the District of Delawar

  • Insider Monkey

    20 Countries with the Highest Plastic Surgery Rates per Capita

    In this article, we will be taking a look at the 20 countries with the highest plastic surgery rates per capita. if you are not interested in learning about transforming trends and the global surge in cosmetic surgeries, head straight to the 5 Countries With The Highest Plastic Surgery Rates Per Capita. Global Surge in […]

  • Insider Monkey

    Sientra, Inc. (NASDAQ:SIEN) Q3 2023 Earnings Call Transcript

    Sientra, Inc. (NASDAQ:SIEN) Q3 2023 Earnings Call Transcript November 9, 2023 Sientra, Inc. misses on earnings expectations. Reported EPS is $-1.31 EPS, expectations were $-0.48. Operator: Good afternoon and welcome to the Sientra Third Quarter 2023 Financial Results Conference Call. My name is Dave. At this time, all participants are in a listen-only mode. After […]